Therapy News and Research

RSS

New gene therapy for wet age-related macular degeneration is on the horizon

Gene therapy is showing promise for one of the most common causes of blindness. Data presented today shows that six patients with wet age-related macular degeneration have, so far, gone at least six months without the need for continued injections to control a disease that typically requires treatment every four to six weeks.

11 Oct 2019

Medical and surgical eye care experts gather in San Francisco for AAO 2019

More than 25,000 are expected to attend the American Academy of Ophthalmology's 123rd annual meeting, AAO 2019, from Oct. 12-15 at the Moscone Center in San Francisco.

11 Oct 2019

Combination drug appears to improve lung health in patients with cystic fibrosis, but with caveats

In adolescent and adult patients with cystic fibrosis taking lumacaftor-ivacaftor (ORKAMBI), the combination drug appears to improve lung function and body weight and reduce the need for intravenous antibiotic treatment, according to a French study published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

11 Oct 2019

As vaping illnesses rise, so do pleas to quit-smoking help lines

These are just a few of the messages that teen vapers texted in September to the new "My Life, My Quit" program, which offers phone, text and chat lines to young people trying to quit smoking in 13 states.

11 Oct 2019

RTKI drugs may not significantly improve survival rates of patients during radiotherapy

Taking certain cancer-fighting drugs while undergoing radiation therapy may not increase survival for patients, but may, instead, increase side effects, according to a team of researchers. The drugs, however, may be beneficial for patients who are not undergoing radiation therapy.

10 Oct 2019

Vaccine against gastrin may slow spread of pancreatic cancer

New research suggests a vaccine that blocks a digestive hormone may slow the spread of pancreatic cancer, potentially increasing survival rates. The study, published ahead of print in the American Journal of Physiology—Gastrointestinal and Liver Physiology, was chosen as an APSselect article for October.

10 Oct 2019

Tips to manage symptoms and flare-ups in children with eczema

Atopic dermatitis (also known as eczema) is a common skin condition in babies. It affects up to 25% of children, and an estimated 60% of people with eczema develop it during their first year of life.

10 Oct 2019

Mediterranean style diet found to relieve symptoms of depression

A new study has added to the existing evidence that a healthy and balanced diet could help reduce the symptoms of depression.

10 Oct 2019

Irish researchers choose Shimmer's Verisense technology to study fatigue in breast cancer patients

Shimmer Research, a global leader in wearable technology for research applications, today announced that a team of researchers from Letterkenny Institute of Technology and Letterkenny University Hospital (LUH) will be using Shimmer's Verisense continuous monitoring platform to study fatigue accurately in individuals with breast cancer.

10 Oct 2019

BIA Separations launches CORNERSTONE Exosome Process Development Solution

BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of its CORNERSTONE Exosome Process Development Solution, designed to help drug-developers overcome critical development bottlenecks in the preparation of exosomes for clinical use.

10 Oct 2019

Scientists find new evidence on latent HIV reservoir

Antiretroviral therapy (ART) can suppress HIV to the point where the virus is nearly undetectable, and people on medication can live many years.

10 Oct 2019

New algorithm hand-picks which cancer mutations are promising targets for immunotherapy

As tumor cells multiply, they often spawn tens of thousands of genetic mutations. Figuring out which ones are the most promising to target with immunotherapy is like finding a few needles in a haystack.

9 Oct 2019

UMD-PRC receives new CDC fund to improve mental health for LGBTQ+ people

The University of Maryland Prevention Research Center is working to improve mental health and health care for LGBTQ+ people with new funding from the U.S. Centers for Disease Control and Prevention.

9 Oct 2019

Initial use of ART alters host environment to allow formation of long-lived HIV reservoir

Antiretroviral therapy (ART) can suppress HIV to the point where the virus is nearly undetectable, and people on medication can live many years. But therapy cannot completely eradicate the virus; it persists in reservoirs inside immune cells, a phenomenon called "latency."

9 Oct 2019

Scientists demonstrate potential method for treating advanced liver cancers

Liver cancer is the second leading cause of cancer-related deaths worldwide. The most common primary liver cancer in adults is known as hepatocellular carcinoma (HCC), and accounts for approximately 780,000 deaths every year.

9 Oct 2019

Unique immune cell linked to remission in patients with triple negative breast cancer

A unique type of immune cell has been discovered in human breast tissue, and breast cancer patients with more of these cells are more likely to survive, finds new research from the Francis Crick Institute and King's College London.

From The Francis Crick Institute 9 Oct 2019

Lab-grown, testosterone-producing cells could help treat hypogonadism

Researchers have managed to grow human, testosterone-producing cells, which could lead to improved treatment options for low testosterone levels.

9 Oct 2019

New study examines care for patients with knee osteoarthritis in the U.S.

A new study published in Arthritis Care & Research provides an overview of U.S. physicians' recommendations for physical therapy, lifestyle counseling, pain medications for treating knee osteoarthritis.

9 Oct 2019

Study explores steroid prescribing rates for patients with inflammatory bowel disease

Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.

9 Oct 2019

Study evaluates role of PET/CT in selecting candidates for peptide receptor radionuclide therapy

A new study published in The Journal of Nuclear Medicine evaluated the role of 68Ga-DOTATATE positron emission tomography/computed tomography in selecting neuroendocrine tumor patients who may benefit from peptide receptor radionuclide therapy.

9 Oct 2019

Therapy News and Research

New gene therapy for wet age-related macular degeneration is on the horizon

Medical and surgical eye care experts gather in San Francisco for AAO 2019

Combination drug appears to improve lung health in patients with cystic fibrosis, but with caveats

As vaping illnesses rise, so do pleas to quit-smoking help lines

RTKI drugs may not significantly improve survival rates of patients during radiotherapy

Vaccine against gastrin may slow spread of pancreatic cancer

Tips to manage symptoms and flare-ups in children with eczema

Mediterranean style diet found to relieve symptoms of depression

Irish researchers choose Shimmer's Verisense technology to study fatigue in breast cancer patients

BIA Separations launches CORNERSTONE Exosome Process Development Solution

Scientists find new evidence on latent HIV reservoir

New algorithm hand-picks which cancer mutations are promising targets for immunotherapy

UMD-PRC receives new CDC fund to improve mental health for LGBTQ+ people

Initial use of ART alters host environment to allow formation of long-lived HIV reservoir

Scientists demonstrate potential method for treating advanced liver cancers

Unique immune cell linked to remission in patients with triple negative breast cancer

Lab-grown, testosterone-producing cells could help treat hypogonadism

New study examines care for patients with knee osteoarthritis in the U.S.

Study explores steroid prescribing rates for patients with inflammatory bowel disease

Study evaluates role of PET/CT in selecting candidates for peptide receptor radionuclide therapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News